Illustrative image – not actual.Promed Group plans to invest Rs.125 crore in the next three years to augment its drug capacity and expand its network in the overseas market.
The company has already set up a manufacturing unit at Nalagarh in Himachal Pradesh and will invest Rs.55 crore for doubling its capacity. It is also in the process of getting regulatory approvals from developed countries for its products and plant.
It is learnt that the European regulating authorities will inspect the facilities by the end of 2008, while US FDA is expected to inspect in the mid-2009. The company anticipates all regulatory approvals by 2011.
